Cargando…
Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma
Pancreatic adenocarcinoma (PAAD), one of the most malignant tumors, not only has abundant mesenchymal components, but is also characterized by an extremely high metastatic risk. The purpose of this study was to construct a model of stroma- and metastasis-associated prognostic signature, aiming to be...
Autores principales: | Zheng, Jia-Hao, Yao, Hong-Fei, Duan, Zong-Hao, Ji, Pei-Xuan, Yang, Jian, Zhu, Yu-Heng, Jia, Qin-Yuan, Yang, Jian-Yu, Liu, De-Jun, Sun, Yong-Wei, Chen, Peng-Cheng, Shi, Pei-Dong, Chen, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696859/ https://www.ncbi.nlm.nih.gov/pubmed/36355508 http://dx.doi.org/10.3390/ph15111336 |
Ejemplares similares
-
Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma
por: Zhao, Jian-Gang, et al.
Publicado: (2023) -
Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
por: Chen, Dongjie, et al.
Publicado: (2021) -
The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma
por: Wang, Lai Mun, et al.
Publicado: (2015) -
Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma
por: Ahmed, Azaz, et al.
Publicado: (2022) -
Targeting Tumor Stroma: Exploiting Apoptotic Priming
por: Mertens, Joachim C., et al.
Publicado: (2012)